TGFB1 and cancer: While several studies have explored ECM remodeling within the lung and the role of TGF-β, these have focused predominantly on the profibrotic response of mesenchymal cells and AT2 cells in disease states such as cancer and idiopathic pulmonary fibrosis (IPF) (20, 33, 46, 47).